258
Views
9
CrossRef citations to date
0
Altmetric
Review

Bibliometric Analysis of Research on the Comorbidity of Cancer and Pain

, , &
Pages 213-228 | Published online: 28 Jan 2021

References

  • Solvik E, Ytrehus S, Utne I, Grov EK. Pain, fatigue, anxiety and depression in older home-dwelling people with cancer. Nursing Open. 2020;7(1):430–438. doi:10.1002/nop2.406
  • Xie F, You Y, Huang J, et al. Association between physical activity and digestive-system cancer: an updated systematic review and meta-analysis. J Sport Health Sci. 2020;30(20):S2095–2546.
  • Xu T, Lei H, Zhang Y, et al. Interventions for cancer-related pain: protocol of an umbrella systematic review and network meta-analysis. Medicine (Baltimore). 2019;98(45):e17844.
  • Vainshelboim B, Lima RM, Myers J. Cardiorespiratory fitness and cancer in women: a prospective pilot study. J Sport Health Sci. 2019;8(5):457–462.
  • Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117–128.
  • Liou KT, Hung TKW, Meghani SH, et al. What if acupuncture were covered by insurance for pain management? A cross-sectional study of cancer patients at one academic center and 11 Community Hospitals. Pain Med. 2019;20(10):2060–2068.
  • Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009;20(8):1420–1433.
  • Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–1006.
  • Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985–1991.
  • Wang X-Q, Peng M-S, Weng L-M, et al. Bibliometric study of the comorbidity of pain and depression research. Neural Plast. 2019;2019:1657498. doi:10.1155/2019/1657498
  • Puetzler J, Feldmann RE Jr, Brascher A-K, Gerhardt A, Benrath J. Improvements in health-related quality of life by comprehensive cancer pain therapy: a pilot study with breast cancer outpatients under palliative chemotherapy. Oncol Res Treat. 2014;37(9):456–462. doi:10.1159/000365537
  • Porter LS, Keefe FJ. Psychosocial issues in cancer pain. Curr Pain Headache Rep. 2011;15(4):263–270.
  • Schmidt BL. The neurobiology of cancer pain. J Oral Maxillofacial Surg. 2015;73(12 Suppl):S132–135.
  • Brown MR, Ramirez JD. Neuroimmune mechanisms in cancer pain. Curr Opin Support Palliat Care. 2015;9(2):103–111.
  • Zyoud SH, Fuchs-Hanusch D. A bibliometric-based survey on AHP and TOPSIS techniques. Expert Syst Appl. 2017;78:158–181.
  • Yang W, Hao X, Qu J, et al. Collaborative networks and thematic trends of research on the application of complementary and alternative medicine in cancer patients: a bibliometric analysis. Complement Ther Clin Pract. 2019;37:58–67.
  • Stout NL, Alfano CM, Belter CW, et al. A bibliometric analysis of the landscape of cancer rehabilitation research (1992-2016). J Natl Cancer Inst. 2018;110(8):815–824.
  • Ugolini D, Neri M, Cesario A, et al. Scientific production in cancer rehabilitation grows higher: a bibliometric analysis. Support Care Cancer. 2012;20(8):1629–1638.
  • Lu K, Yu S, Yu M, et al. Bibliometric analysis of tumor immunotherapy studies. Med Sci Monitor. 2018;24:3405–3414.
  • Moura LKB, Mobin M, Matos FTC, et al. Bibliometric analysis on the risks of oral cancer for people living with HIV/AIDS. Iran J Public Health. 2017;46(11):1583–1585.
  • Glynn RW, Chin JZ, Kerin MJ, Sweeney KJ. Representation of cancer in the medical literature–a bibliometric analysis. PLoS One. 2010;5(11):e13902.
  • Lewison G, Purushotham A, Mason M, McVie G, Sullivan R. Understanding the impact of public policy on cancer research: a bibliometric approach. Eur J Cancer. 2010;46(5):912–919.
  • Liang YD, Li Y, Zhao J, et al. Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res. 2017;10:951–964.
  • Agarwal KK, Singla S, Arora G, Bal C. Lu-177-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a Phase II study. Eur J Nucl Med Mol Imaging. 2015;42(1):79–88.
  • Altundag K, Dizdar O, Ozsaran Z, et al. Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain. Onkologie. 2012;35(5):254–258.
  • Sibley C, Ayers C, King B, Browning T, Kwon JK. Decreasing patient dwell times for outpatient cardiac nuclear medicine studies: the benefits of SMART goals, scope limitations, and society guidelines in quality improvement. Curr Probl Diagn Radiol. 2020;49(5):333–336.
  • Takahashi PY, Quigg SM, Croghan IT, Schroeder DR, Ebbert JO. SMART goals setting and biometric changes in obese adults with multimorbidity: secondary analysis of a randomized controlled trial. SAGE Open Med. 2019;7:2050312119858042.
  • Caraceni A, Hanks GR, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):E58–E68.
  • Bendixen M, Jorgensen OD, Kronborg C, Andersen C, Licht PB. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. Lancet Oncol. 2016;17(6):836–844.
  • Berenson J, Pflugmacher R, Jarzem P, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 2011;12(3):225–235.
  • Portenoy RK. Treatment of cancer pain. Lancet. 2011;377(9784):2236–2247.
  • Ripamonti CI, Santini D, Maranzano E, et al. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol. 2012;23:139–154.
  • Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet. 2011;377(9784):2226–2235.
  • Johnson JR, Burnell-Nugent M, Lossignol D, et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167–179.
  • van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070.
  • Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2-guidance. Pain Phys. 2012;15(3):S67–S116.
  • Reid KJ, Harker J, Bala MM, et al. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin. 2011;27(2):449–462.
  • Hagen NA, Biondo P, Stiles C. Assessment and management of breakthrough pain in cancer patients: current approaches and emerging research. Curr Pain Headache Rep. 2008;12(4):241–248.
  • Zhu XC, Zhang JL, Ge CT, et al. Advances in cancer pain from bone metastasis. Drug Des Devel Ther. 2015;9:4239–4245.
  • Zucco F, Bonezzi C, Fornasari D. Breakthrough cancer pain (BTcP): a synthesis of taxonomy, pathogenesis, therapy, and good clinical practice in adult patients in Italy. Adv Ther. 2014;31(7):657–682.
  • Hagen NA, Biondo P, Stiles C. Assessment and management of breakthrough pain in cancer patients: current approaches and emerging research. Curr Pain Headache Rep. 2008;12(4):241–248.
  • Gong LY, Cai H, Zhou QF, Kong XM. beta-Elemene alleviates bone cancer-related pain in rats by modulating N-methyl-D-aspartate receptor 2B subunit. Trop J Pharm Res. 2018;17(4):597–603.